Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 1,476 - 1,500 of 2,875 « 1 … 58 59 60 61 62 … 115 » Other Oncogene-Driven Cancers Collin Blakely, MD, PhD View PDF Other Oncogene-Driven Cancers Collin Blakely, MD, PhD View Video EGFR-Mutated Lung Cancers Collin Blakely, MD, PhD View PDF EGFR-Mutated Lung Cancers Collin Blakely, MD, PhD View Video EGFR Mutated Lung Cancer - Advanced Stage Collin Blakely, MD, PhD View PDF EGFR Mutated Lung Cancer - Advanced Stage Collin Blakely, MD, PhD View Video EGFR Mutated Lung Cancer - Advanced Stage Collin Blakely, MD, PhD View PDF EGFR Mutated Lung Cancer - Advanced Stage Collin Blakely, MD, PhD View Video ALK, ROS1 & NTRK Mutations in NSCLC Corey Langer, MD View PDF ALK, ROS1 & NTRK Mutations in NSCLC Corey Langer, MD View Video Stage III Non-Surgical Candidate NSCLC – Controversies in this Arena (Tumors with Actionable Genes and No PD-L1 Expression) Corey Langer, MD View PDF Building the Case for HER-2 Inhibitors in NSCLC Corey Langer, MD View PDF Building the Case for HER-2 Inhibitors in NSCLC Corey Langer, MD View Video Stage III Non-Surgical Candidate NSCLC – Controversies in this Arena (Tumors with Actionable Genes and No PD-L1 Expression) Corey Langer, MD View Video Targeted Therapies in Lung Cancer D. Ross Camidge, MD, PhD View PDF Targeted Therapies in Lung Cancer D. Ross Camidge, MD, PhD View Video EGFR Mutated Lung Cancer - Advanced Stage David Gandara, MD View PDF EGFR Mutated Lung Cancer - Advanced Stage David Gandara, MD View PDF Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC David Gandara, MD View PDF Predictive Biomarkers for Immunotherapy: Non-Small Cell Lung Cancer as a Model of Tumor Heterogeneity David Gandara, MD View Video EGFR Mutated Lung Cancer - Advanced Stage David Gandara, MD View Video Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers David Gandara, MD View Video Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC David Gandara, MD View Video EGFR Mutated Lung Cancer - Advanced Stage David Gandara, MD View PDF EGFR Mutated Lung Cancer - Advanced Stage David Gandara, MD View Video
